- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Small-cell Lung Cancer in United Kingdom
Total 7919 results
-
Duke UniversityRegeneron PharmaceuticalsRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedSmall Cell Lung Carcinoma | Small Cell Lung CancerUnited States, Canada, United Kingdom
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedSmall-Cell Lung CancerUnited States, France
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
VA Office of Research and DevelopmentVA Greater Los Angeles Healthcare SystemNot yet recruitingEZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNon Small Cell Lung CancerUnited States
-
Taofeek OwonikokoNational Cancer Institute (NCI); Cardiff OncologyActive, not recruitingSmall Cell Lung Carcinoma | Small-cell Lung CancerUnited States
-
Cyclacel Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesTerminatedNon-small Cell Lung CancerUnited States
-
University of UtahBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedNon-Small-Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterUniversity of WashingtonCompleted
-
New Mexico Cancer Care AllianceNovartis; Fred Hutchinson Cancer CenterCompletedNon-small Cell Lung CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
Megan Daly, MDGenentech, Inc.Active, not recruitingStage I Non-Small Cell Lung CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterPeregrine PharmaceuticalsCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
Stanford UniversityEli Lilly and Company; Genentech, Inc.CompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
GlaxoSmithKlineCompletedLung Cancer, Small Cell | Recurrent Small-cell Lung Cancer (SCLC)United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNon-small Cell Lung CancerUnited States
-
ACEA Therapeutics, Inc.TerminatedNon Small Cell Lung CancerUnited States, Spain, France
-
AgennixUnknownNon Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Medical College of WisconsinNot yet recruitingNon Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterTerminated
-
University of ChicagoTerminatedNon-small Cell Lung CancerUnited States
-
Eisai Inc.CompletedNon-small Cell Lung CancerCanada, United States, United Kingdom, Australia, Israel, Russian Federation, Czech Republic, France, Greece, Hungary, Poland
-
European Organisation for Research and Treatment...Active, not recruitingNon Small Cell Lung CancerNetherlands, Spain, France, United Kingdom, Norway, Jordan, Belgium
-
Nerissa T. ViolaNot yet recruitingNon Small Cell Lung CancerUnited States
-
Carevive Systems, Inc.CompletedNon Small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonTerminatedNon Small Cell Lung CancerUnited States
-
SanofiCompletedCancer | Non-small Cell Lung CancerUnited States
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
Teligene USRecruitingNon-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
Daiichi Sankyo, Inc.CompletedNon-small Cell Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Foundation Medicine; Addario Lung Cancer Medical...CompletedSmall Cell Lung Cancer | Non-small Cell Lung CancerUnited States
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Illinois CancerCare, P.C.TerminatedNon Small Cell Lung CancerUnited States
-
Shadia Jalal, MDAstex Pharmaceuticals, Inc.; Indiana University School of MedicineCompletedSmall Cell Lung Cancer | Extensive-stage Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States